Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Olencki

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1996
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancyT Olencki, J Finke, R Tubbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findingsR M Bukowski, T Olencki, H Gunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapyR M Bukowski, P Rayman, R Uzzo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of responseR M Bukowski, T Olencki, Q Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinomaR M Bukowski, P Rayman, L Molto, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1996
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancyT Olencki, J Finke, R Tubbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findingsR M Bukowski, T Olencki, H Gunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapyR M Bukowski, P Rayman, R Uzzo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of responseR M Bukowski, T Olencki, Q Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinomaR M Bukowski, P Rayman, L Molto, et al.
Pageof 3